Baidu
map

危重病人超90% 北京朝阳医院急诊抢救和留观区都是重病号

2019-07-10 李子君 健康界

急诊分级、病床统一管理……首都医科大学附属北京朝阳医院(下称北京朝阳医院)正采取一系列举措改善医疗服务质量。7月10日,健康界从北京朝阳医院获悉,医院日前成立大型检查集中预约中心和一站式住院服务,将30%床位纳入统一管理。北京20家三级医院于2019年5月开始实施预检分级分诊就诊,在媒体沟通会上,北京朝阳医院急诊科副主任梅雪透露,目前,北京朝阳医院急诊科内危重病人占比已经超过90%。30%床位纳入

急诊分级、病床统一管理……首都医科大学附属北京朝阳医院(下称北京朝阳医院)正采取一系列举措改善医疗服务质量。7月10日,健康界从北京朝阳医院获悉,医院日前成立大型检查集中预约中心和一站式住院服务,将30%床位纳入统一管理

北京20家三级医院于2019年5月开始实施预检分级分诊就诊,在媒体沟通会上,北京朝阳医院急诊科副主任梅雪透露,目前,北京朝阳医院急诊科内危重病人占比已经超过90%。

30%床位纳入统一管理

日前,北京朝阳医院成立一站式大型检查集中预约中心,整合、重组各项检查项目流程,替代原来各个医技科室分散预约。同时,预约中心对接自助机、APP等自助设备,实现患者检查的自助报到等功能,既优化了预约和报到流程,也缓解了患者在院内流动的盲目性,缩短了患者在院滞留时间。针对外地患者,医院会通过资源调配,将外地患者的检查安排在当天完成,缓解了患者就医流程的难点。

据北京朝阳医院副院长李晓北介绍,医院设立一站式住院服务中心,实施床位弹性管理,全院30%的床位打破了科室间、科内主诊组间床位壁垒,床位集中管理、按需弹性调配,保证疑难、急、危重症患者收治。并且畅通患者入院流程,手术科室患者在办理住院当日即可完善部分术前检查,缩短术前平均住院日。

急诊抢救室和抢救留观区中超九成是危重病人

从2019年5月1日起,包括北京朝阳医院在内的北京20家三级医院的急诊科再无“先来后到”,统一实施急诊预检分诊分级就诊(简称“急诊分级”)。

目前,北京朝阳医院已按照北京市医管局的统一要求完全实现了急诊预检分级就诊。梅雪表示,患者就诊急诊,首先到急诊科分诊台进行预检分级,按病情严重程度患者被分为“濒危、危重、急症和非急症”1-4级;之后,依照级别顺序接受诊疗,遵循从重到轻、从病情迅速变化到相对稳定的原则,分诊台安排患者就诊顺序,优先处理较重病人。病人病情的级别决定了诊疗次序,而不是“先来后到”。这个过程会尽量减少分诊护士主观判断,而是护士依据心电图结果等客观数据将患者进行分级。

医院将1级和2级患者安置在代表病情危重的红区,优先进行诊疗,送入抢救室或者复苏室进行救治。3级患者归入代表急症患者的黄色区域,4级患者则归入代表非急症的绿色区域。北京朝阳医院本部急诊医学科与六里屯社区医院、朝阳抢救中心疗区、怀柔医院急诊医学科成立医联体。4级非急症患者或者经过抢救后已稳定的患者转诊到医联体成员医院进行后续治疗。

“实施急诊分级分诊提高了科室管理质量,实现医疗资源的合理分配,提高了科室运行效率。”梅雪表示,在实施急诊分级之前,每天下午和晚间是急诊就诊的高峰时段,医生诊疗一名患者经常只有两到三分钟,连喝水和上厕所的时间都没有,很难实现高标准的医疗质量。相比两年前,如今的北京朝阳医院急诊科诊疗量提升20%,但每名医生看诊时间可以保持10分钟左右。统计显示,在北京朝阳医院急诊抢救室和抢救留观区的危重症患者占比已经超过90%,并且几乎没有加床,初步实现了三级医院病人结构调整的目的。

急诊科一直是各医院病人投诉量较高的科室。在急诊预检分诊之前,北京朝阳医院急诊几乎每天都能收到病人投诉,目前每月投诉只有两三起。“过去投诉的大部分是病情相对较重患者的家属,将病人分级管理之后,重症患者会优先就医,这是急诊科投诉量大幅降低的原因。”梅雪说。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1690473, encodeId=861016904e3f5, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Dec 15 18:42:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369554, encodeId=660d369554aa, content=学习了,写得不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Fri Jul 12 23:22:18 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471373, encodeId=3df714e1373a6, content=<a href='/topic/show?id=ac13558e9cb' target=_blank style='color:#2F92EE;'>#抢救#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55879, encryptionId=ac13558e9cb, topicName=抢救)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be1a7117101, createdName=lfyang, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533252, encodeId=21fe15332525c, content=<a href='/topic/show?id=c3c236e5229' target=_blank style='color:#2F92EE;'>#危重病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36752, encryptionId=c3c236e5229, topicName=危重病人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53bc12401014, createdName=listen322, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554680, encodeId=3b83155468026, content=<a href='/topic/show?id=fe8360e85a3' target=_blank style='color:#2F92EE;'>#朝阳医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60785, encryptionId=fe8360e85a3, topicName=朝阳医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81b14545147, createdName=whlxd, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369419, encodeId=075f36941903, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jul 10 17:50:52 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1690473, encodeId=861016904e3f5, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Dec 15 18:42:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369554, encodeId=660d369554aa, content=学习了,写得不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Fri Jul 12 23:22:18 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471373, encodeId=3df714e1373a6, content=<a href='/topic/show?id=ac13558e9cb' target=_blank style='color:#2F92EE;'>#抢救#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55879, encryptionId=ac13558e9cb, topicName=抢救)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be1a7117101, createdName=lfyang, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533252, encodeId=21fe15332525c, content=<a href='/topic/show?id=c3c236e5229' target=_blank style='color:#2F92EE;'>#危重病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36752, encryptionId=c3c236e5229, topicName=危重病人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53bc12401014, createdName=listen322, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554680, encodeId=3b83155468026, content=<a href='/topic/show?id=fe8360e85a3' target=_blank style='color:#2F92EE;'>#朝阳医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60785, encryptionId=fe8360e85a3, topicName=朝阳医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81b14545147, createdName=whlxd, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369419, encodeId=075f36941903, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jul 10 17:50:52 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
    2019-07-12 太子-大医精诚

    学习了,写得不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1690473, encodeId=861016904e3f5, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Dec 15 18:42:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369554, encodeId=660d369554aa, content=学习了,写得不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Fri Jul 12 23:22:18 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471373, encodeId=3df714e1373a6, content=<a href='/topic/show?id=ac13558e9cb' target=_blank style='color:#2F92EE;'>#抢救#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55879, encryptionId=ac13558e9cb, topicName=抢救)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be1a7117101, createdName=lfyang, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533252, encodeId=21fe15332525c, content=<a href='/topic/show?id=c3c236e5229' target=_blank style='color:#2F92EE;'>#危重病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36752, encryptionId=c3c236e5229, topicName=危重病人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53bc12401014, createdName=listen322, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554680, encodeId=3b83155468026, content=<a href='/topic/show?id=fe8360e85a3' target=_blank style='color:#2F92EE;'>#朝阳医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60785, encryptionId=fe8360e85a3, topicName=朝阳医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81b14545147, createdName=whlxd, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369419, encodeId=075f36941903, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jul 10 17:50:52 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
    2019-07-12 lfyang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1690473, encodeId=861016904e3f5, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Dec 15 18:42:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369554, encodeId=660d369554aa, content=学习了,写得不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Fri Jul 12 23:22:18 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471373, encodeId=3df714e1373a6, content=<a href='/topic/show?id=ac13558e9cb' target=_blank style='color:#2F92EE;'>#抢救#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55879, encryptionId=ac13558e9cb, topicName=抢救)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be1a7117101, createdName=lfyang, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533252, encodeId=21fe15332525c, content=<a href='/topic/show?id=c3c236e5229' target=_blank style='color:#2F92EE;'>#危重病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36752, encryptionId=c3c236e5229, topicName=危重病人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53bc12401014, createdName=listen322, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554680, encodeId=3b83155468026, content=<a href='/topic/show?id=fe8360e85a3' target=_blank style='color:#2F92EE;'>#朝阳医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60785, encryptionId=fe8360e85a3, topicName=朝阳医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81b14545147, createdName=whlxd, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369419, encodeId=075f36941903, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jul 10 17:50:52 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1690473, encodeId=861016904e3f5, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Dec 15 18:42:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369554, encodeId=660d369554aa, content=学习了,写得不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Fri Jul 12 23:22:18 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471373, encodeId=3df714e1373a6, content=<a href='/topic/show?id=ac13558e9cb' target=_blank style='color:#2F92EE;'>#抢救#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55879, encryptionId=ac13558e9cb, topicName=抢救)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be1a7117101, createdName=lfyang, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533252, encodeId=21fe15332525c, content=<a href='/topic/show?id=c3c236e5229' target=_blank style='color:#2F92EE;'>#危重病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36752, encryptionId=c3c236e5229, topicName=危重病人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53bc12401014, createdName=listen322, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554680, encodeId=3b83155468026, content=<a href='/topic/show?id=fe8360e85a3' target=_blank style='color:#2F92EE;'>#朝阳医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60785, encryptionId=fe8360e85a3, topicName=朝阳医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81b14545147, createdName=whlxd, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369419, encodeId=075f36941903, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jul 10 17:50:52 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1690473, encodeId=861016904e3f5, content=<a href='/topic/show?id=fdb336e49bb' target=_blank style='color:#2F92EE;'>#危重病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36749, encryptionId=fdb336e49bb, topicName=危重病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27f729051889, createdName=xinmeili, createdTime=Sun Dec 15 18:42:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369554, encodeId=660d369554aa, content=学习了,写得不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Fri Jul 12 23:22:18 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471373, encodeId=3df714e1373a6, content=<a href='/topic/show?id=ac13558e9cb' target=_blank style='color:#2F92EE;'>#抢救#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55879, encryptionId=ac13558e9cb, topicName=抢救)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be1a7117101, createdName=lfyang, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533252, encodeId=21fe15332525c, content=<a href='/topic/show?id=c3c236e5229' target=_blank style='color:#2F92EE;'>#危重病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36752, encryptionId=c3c236e5229, topicName=危重病人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53bc12401014, createdName=listen322, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554680, encodeId=3b83155468026, content=<a href='/topic/show?id=fe8360e85a3' target=_blank style='color:#2F92EE;'>#朝阳医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60785, encryptionId=fe8360e85a3, topicName=朝阳医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81b14545147, createdName=whlxd, createdTime=Fri Jul 12 07:42:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369419, encodeId=075f36941903, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jul 10 17:50:52 CST 2019, time=2019-07-10, status=1, ipAttribution=)]
    2019-07-10 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

Intens Care Med:非药物干预在降低危重病人谵妄发生率和持续时间方面的疗效分析

由此可见,目前的证据不支持使用非药物干预措施来降低危重病人的谵妄发生率和持续时间。未来的研究应该考虑精心设计和充分描述的多种组合的干预措施,并充分定义结局指标。

Resp Care:危重病患者预先使用高流量鼻导管

建议使用高流量鼻导管(HFNC)可能是急性缺氧性呼吸衰竭患者的一线治疗方法。本研究的目的是确定拟使用HFNC是否减少ICU患者的非计划插管和不良结果的发生。

Intens Care Med:危重病人血清乳酸的预后价值

由此可见,即使在对混杂因素进行校正之后,较低的Δ24Lac也与危重病人的不良结局密切相关。Δ24Lac可能成为危重病危险分层的独立、易得和重要的指标参数。

Crit Care:危重病人经皮气管切开术是选择垂直还是横向皮肤切口?

由此可见,这项回顾性研究显示重症患者PT的横向皮肤切口导致整体并发症显著减少,尤其是气管切开术部位的溃疡。

Intens Care Med:尿肌酐排泄与危重病人的短期和长期死亡率有关

由此可见,在没有严重肾功能不全的ICU患者中,较低的尿肌酐排泄与短期和长期死亡率相关,而与年龄、性别、肾功能和疾病特征无关,其强调了肌肉质量可作为死亡率的危险因素,而UCE可作为相关生物标志物。

中国循环杂志:替格瑞洛负荷后急性左心衰8例报告,危重病人或许谨慎使用?

新疆医科大学附属中医医院和上海交通大学附属第九医院的三位医生,报告了8个急性冠状动脉综合征(ACS)患者服用负荷量替格瑞洛180 mg出现急性左心衰竭的病例。

Baidu
map
Baidu
map
Baidu
map